121 related articles for article (PubMed ID: 33382206)
1. Multifunctionalized Gold Sub-Nanometer Particles for Sensitizing Radiotherapy against Glioblastoma.
Dong CY; Hong S; Zheng DW; Huang QX; Liu FS; Zhong ZL; Zhang XZ
Small; 2021 Feb; 17(5):e2006582. PubMed ID: 33382206
[TBL] [Abstract][Full Text] [Related]
2. Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization.
Joh DY; Sun L; Stangl M; Al Zaki A; Murty S; Santoiemma PP; Davis JJ; Baumann BC; Alonso-Basanta M; Bhang D; Kao GD; Tsourkas A; Dorsey JF
PLoS One; 2013; 8(4):e62425. PubMed ID: 23638079
[TBL] [Abstract][Full Text] [Related]
3. Technical feasibility of [
Verhoeven J; Bolcaen J; De Meulenaere V; Kersemans K; Descamps B; Donche S; Van den Broecke C; Boterberg T; Kalala JP; Deblaere K; Vanhove C; De Vos F; Goethals I
Radiat Oncol; 2019 May; 14(1):89. PubMed ID: 31146757
[TBL] [Abstract][Full Text] [Related]
4. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma.
Geng L; Shinohara ET; Kim D; Tan J; Osusky K; Shyr Y; Hallahan DE
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):263-71. PubMed ID: 16274936
[TBL] [Abstract][Full Text] [Related]
5. Tumor cell-targeting radiotherapy in the treatment of glioblastoma multiforme using linear accelerators.
Chiang CS; Shih IJ; Shueng PW; Kao M; Zhang LW; Chen SF; Chen MH; Liu TY
Acta Biomater; 2021 Apr; 125():300-311. PubMed ID: 33609743
[TBL] [Abstract][Full Text] [Related]
6. Failure of Inositol Trispyrophosphate to Enhance Highly Effective Radiotherapy of GL261 Glioblastoma in Mice.
Iyengar S; Schwartz D
Anticancer Res; 2017 Mar; 37(3):1121-1125. PubMed ID: 28314273
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: a proof-of-concept study.
Stegen B; Nieto A; Albrecht V; Maas J; Orth M; Neumaier K; Reinhardt S; Weick-Kleemann M; Goetz W; Reinhart M; Parodi K; Belka C; Niyazi M; Lauber K
Radiat Oncol; 2020 Jan; 15(1):19. PubMed ID: 31969174
[TBL] [Abstract][Full Text] [Related]
8. KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma.
Ciesielski MJ; Bu Y; Munich SA; Teegarden P; Smolinski MP; Clements JL; Lau JYN; Hangauer DG; Fenstermaker RA
J Neurooncol; 2018 Dec; 140(3):519-527. PubMed ID: 30238350
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitizing Fe-Au nanocapsules (hybridosomes®) increase survival of GL261 brain tumor-bearing mice treated by radiotherapy.
Goubault C; Jarry U; Bostoën M; Éliat PA; Kahn ML; Pedeux R; Guillaudeux T; Gauffre F; Chevance S
Nanomedicine; 2022 Feb; 40():102499. PubMed ID: 34843982
[TBL] [Abstract][Full Text] [Related]
10. Delivering siRNA and Chemotherapeutic Molecules Across BBB and BTB for Intracranial Glioblastoma Therapy.
Yang ZZ; Gao W; Liu YJ; Pang N; Qi XR
Mol Pharm; 2017 Apr; 14(4):1012-1022. PubMed ID: 28252970
[TBL] [Abstract][Full Text] [Related]
11. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
Wang D; Wang C; Wang L; Chen Y
Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
[TBL] [Abstract][Full Text] [Related]
13. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.
Chang JE; Khuntia D; Robins HI; Mehta MP
Clin Adv Hematol Oncol; 2007 Nov; 5(11):894-902, 907-15. PubMed ID: 18185489
[TBL] [Abstract][Full Text] [Related]
15. A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma.
Tamborini M; Locatelli E; Rasile M; Monaco I; Rodighiero S; Corradini I; Franchini MC; Passoni L; Matteoli M
ACS Nano; 2016 Feb; 10(2):2509-20. PubMed ID: 26745323
[TBL] [Abstract][Full Text] [Related]
16. Locoregional Confinement and Major Clinical Benefit of
Séhédic D; Chourpa I; Tétaud C; Griveau A; Loussouarn C; Avril S; Legendre C; Lepareur N; Wion D; Hindré F; Davodeau F; Garcion E
Theranostics; 2017; 7(18):4517-4536. PubMed ID: 29158842
[TBL] [Abstract][Full Text] [Related]
17. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
[TBL] [Abstract][Full Text] [Related]
18. Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma.
Zschaeck S; Wust P; Graf R; Misch M; Onken J; Ghadjar P; Badakhshi H; Florange J; Budach V; Kaul D
Radiat Oncol; 2018 Dec; 13(1):251. PubMed ID: 30567592
[TBL] [Abstract][Full Text] [Related]
19. Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival?
Tini P; Nardone V; Pastina P; Marampon F; Sebaste L; Cerase A; Tombolini V; Pirtoli L; Mazzei MA
Clin Neurol Neurosurg; 2019 Sep; 184():105445. PubMed ID: 31325903
[TBL] [Abstract][Full Text] [Related]
20. Novel therapies hijack the blood-brain barrier to eradicate glioblastoma cancer stem cells.
Vengoji R; Ponnusamy MP; Rachagani S; Mahapatra S; Batra SK; Shonka N; Macha MA
Carcinogenesis; 2019 Mar; 40(1):2-14. PubMed ID: 30475990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
